1,2-dimethylhydrazine increases expression ISO Inpp5d (Mus musculus) 6480464 1 and 2-Dimethylhydrazine results in increased expression of INPP5D mRNA CTD PMID:22206623 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of INPP5D mRNA CTD PMID:25380136 17alpha-ethynylestradiol increases expression EXP 6480464 Ethinyl Estradiol results in increased expression of INPP5D mRNA CTD PMID:12655037 17beta-estradiol multiple interactions ISO INPP5D (Homo sapiens) 6480464 [Estradiol co-treated with TGFB1 protein] results in decreased expression of INPP5D mRNA CTD PMID:30165855 17beta-estradiol multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of INPP5D mRNA CTD PMID:32741896 17beta-estradiol 3-benzoate multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of INPP5D mRNA CTD PMID:32741896 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of INPP5D mRNA CTD PMID:22298810 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of INPP5D mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of INPP5D mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Inpp5d (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of INPP5D mRNA CTD PMID:26377647 and PMID:28922406 3,4-methylenedioxymethamphetamine increases expression ISO Inpp5d (Mus musculus) 6480464 N-Methyl-3 and 4-methylenedioxyamphetamine results in increased expression of INPP5D mRNA CTD PMID:26251327 4-hydroxyphenyl retinamide decreases expression ISO Inpp5d (Mus musculus) 6480464 Fenretinide results in decreased expression of INPP5D mRNA CTD PMID:28973697 5-aza-2'-deoxycytidine affects expression ISO INPP5D (Homo sapiens) 6480464 Decitabine affects the expression of INPP5D mRNA CTD PMID:23300844 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of INPP5D mRNA CTD PMID:30047161 acetamide increases expression EXP 6480464 acetamide results in increased expression of INPP5D mRNA CTD PMID:31881176 acrylamide decreases expression ISO INPP5D (Homo sapiens) 6480464 Acrylamide results in decreased expression of INPP5D mRNA CTD PMID:32763439 aflatoxin B1 increases methylation ISO INPP5D (Homo sapiens) 6480464 Aflatoxin B1 results in increased methylation of INPP5D intron CTD PMID:30157460 Aflatoxin B2 alpha increases methylation ISO INPP5D (Homo sapiens) 6480464 aflatoxin B2 results in increased methylation of INPP5D intron CTD PMID:30157460 all-trans-retinoic acid decreases expression ISO INPP5D (Homo sapiens) 6480464 Tretinoin results in decreased expression of INPP5D mRNA CTD PMID:23830798 and PMID:33167477 amitrole increases expression EXP 6480464 Amitrole results in increased expression of INPP5D mRNA CTD PMID:30047161 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of INPP5D mRNA CTD PMID:16483693 antirheumatic drug decreases expression ISO INPP5D (Homo sapiens) 6480464 Antirheumatic Agents results in decreased expression of INPP5D mRNA CTD PMID:24449571 aripiprazole multiple interactions ISO INPP5D (Homo sapiens) 6480464 [Aripiprazole co-treated with Ozone] results in increased expression of INPP5D mRNA CTD PMID:31476115 benzo[a]pyrene increases expression ISO Inpp5d (Mus musculus) 6480464 Benzo(a)pyrene results in increased expression of INPP5D mRNA CTD PMID:21569818 benzo[a]pyrene increases methylation ISO INPP5D (Homo sapiens) 6480464 Benzo(a)pyrene results in increased methylation of INPP5D promoter CTD PMID:27901495 benzo[a]pyrene affects methylation ISO INPP5D (Homo sapiens) 6480464 Benzo(a)pyrene affects the methylation of INPP5D exon and Benzo(a)pyrene affects the methylation of INPP5D intron CTD PMID:30157460 benzo[a]pyrene increases expression ISO INPP5D (Homo sapiens) 6480464 Benzo(a)pyrene results in increased expression of INPP5D mRNA CTD PMID:22316170 and PMID:32234424 benzo[e]pyrene increases methylation ISO INPP5D (Homo sapiens) 6480464 benzo(e)pyrene results in increased methylation of INPP5D intron CTD PMID:30157460 benzo[e]pyrene decreases methylation ISO INPP5D (Homo sapiens) 6480464 benzo(e)pyrene results in decreased methylation of INPP5D exon CTD PMID:30157460 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of INPP5D mRNA CTD PMID:25181051 butanal decreases expression ISO INPP5D (Homo sapiens) 6480464 butyraldehyde results in decreased expression of INPP5D mRNA CTD PMID:26079696 cadmium atom multiple interactions ISO INPP5D (Homo sapiens) 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of INPP5D mRNA CTD PMID:35301059 cadmium dichloride increases methylation EXP 6480464 Cadmium Chloride results in increased methylation of INPP5D promoter CTD PMID:22457795 cadmium dichloride multiple interactions ISO INPP5D (Homo sapiens) 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of INPP5D mRNA CTD PMID:35301059 caffeine affects phosphorylation ISO INPP5D (Homo sapiens) 6480464 Caffeine affects the phosphorylation of INPP5D protein CTD PMID:35688186 cannabidiol decreases expression ISO Inpp5d (Mus musculus) 6480464 Cannabidiol results in decreased expression of INPP5D mRNA CTD PMID:30742662 carbamazepine affects expression ISO INPP5D (Homo sapiens) 6480464 Carbamazepine affects the expression of INPP5D mRNA CTD PMID:25979313 chlorpyrifos increases expression EXP 6480464 Chlorpyrifos results in increased expression of INPP5D mRNA CTD PMID:18668222 chlorpyrifos increases expression ISO Inpp5d (Mus musculus) 6480464 Chlorpyrifos results in increased expression of INPP5D mRNA CTD PMID:37019170 choline multiple interactions ISO Inpp5d (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of INPP5D mRNA CTD PMID:20938992 cisplatin affects expression ISO INPP5D (Homo sapiens) 6480464 Cisplatin affects the expression of INPP5D mRNA CTD PMID:23300844 cisplatin increases expression ISO INPP5D (Homo sapiens) 6480464 Cisplatin results in increased expression of INPP5D mRNA CTD PMID:27392435 clotrimazole increases expression EXP 6480464 Clotrimazole results in increased expression of INPP5D mRNA CTD PMID:30047161 copper(II) sulfate decreases expression ISO INPP5D (Homo sapiens) 6480464 Copper Sulfate results in decreased expression of INPP5D mRNA CTD PMID:19549813 crocidolite asbestos decreases expression ISO Inpp5d (Mus musculus) 6480464 Asbestos and Crocidolite results in decreased expression of INPP5D mRNA CTD PMID:29279043 deoxynivalenol affects phosphorylation ISO Inpp5d (Mus musculus) 6480464 deoxynivalenol affects the phosphorylation of INPP5D protein CTD PMID:23352502 dextran sulfate multiple interactions ISO Inpp5d (Mus musculus) 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of INPP5D mRNA CTD PMID:29950665 diazinon increases expression EXP 6480464 Diazinon results in increased expression of INPP5D mRNA CTD PMID:29108742 dicrotophos increases expression ISO INPP5D (Homo sapiens) 6480464 dicrotophos results in increased expression of INPP5D mRNA CTD PMID:28302478 dieldrin affects expression EXP 6480464 Dieldrin affects the expression of INPP5D mRNA CTD PMID:22546817 dorsomorphin multiple interactions ISO INPP5D (Homo sapiens) 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 ellagic acid increases expression ISO INPP5D (Homo sapiens) 6480464 Ellagic Acid results in increased expression of INPP5D mRNA CTD PMID:12002526 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of INPP5D mRNA CTD PMID:29391264 and PMID:31464424 entinostat increases expression ISO INPP5D (Homo sapiens) 6480464 entinostat results in increased expression of INPP5D mRNA CTD PMID:26272509 entinostat multiple interactions ISO INPP5D (Homo sapiens) 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of INPP5D mRNA CTD PMID:27188386 ethanol multiple interactions ISO Inpp5d (Mus musculus) 6480464 [Carbon Tetrachloride co-treated with Ethanol] results in increased expression of INPP5D mRNA CTD PMID:30517762 ethanol affects splicing ISO Inpp5d (Mus musculus) 6480464 Ethanol affects the splicing of INPP5D mRNA CTD PMID:30319688 ethanol increases expression ISO Inpp5d (Mus musculus) 6480464 Ethanol results in increased expression of INPP5D mRNA CTD PMID:30319688 folic acid multiple interactions ISO Inpp5d (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of INPP5D mRNA CTD PMID:20938992 folic acid decreases expression ISO Inpp5d (Mus musculus) 6480464 Folic Acid results in decreased expression of INPP5D mRNA CTD PMID:25629700 folpet decreases expression ISO Inpp5d (Mus musculus) 6480464 folpet results in decreased expression of INPP5D mRNA CTD PMID:31558096 formaldehyde decreases expression ISO INPP5D (Homo sapiens) 6480464 Formaldehyde results in decreased expression of INPP5D mRNA CTD PMID:28937961 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of INPP5D mRNA CTD PMID:22061828 and PMID:33387578 ketamine increases expression EXP 6480464 Ketamine results in increased expression of INPP5D mRNA CTD PMID:20080153 L-methionine multiple interactions ISO Inpp5d (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of INPP5D mRNA CTD PMID:20938992 Lasiocarpine increases expression ISO INPP5D (Homo sapiens) 6480464 lasiocarpine results in increased expression of INPP5D mRNA CTD PMID:32234424 lipopolysaccharide multiple interactions ISO INPP5D (Homo sapiens) 6480464 [S-(1 more ... CTD PMID:35811015 lipopolysaccharide decreases expression ISO INPP5D (Homo sapiens) 6480464 Lipopolysaccharides results in decreased expression of INPP5D mRNA CTD PMID:35811015 maneb multiple interactions ISO Inpp5d (Mus musculus) 6480464 [Maneb co-treated with Paraquat] results in decreased expression of INPP5D mRNA CTD PMID:36117858 MeIQx increases expression ISO INPP5D (Homo sapiens) 6480464 2-amino-3 more ... CTD PMID:20816883 mercury dibromide increases expression ISO INPP5D (Homo sapiens) 6480464 mercuric bromide results in increased expression of INPP5D mRNA CTD PMID:26272509 mercury dibromide multiple interactions ISO INPP5D (Homo sapiens) 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of INPP5D mRNA CTD PMID:27188386 methapyrilene increases methylation ISO INPP5D (Homo sapiens) 6480464 Methapyrilene results in increased methylation of INPP5D intron CTD PMID:30157460 methapyrilene decreases methylation ISO INPP5D (Homo sapiens) 6480464 Methapyrilene results in decreased methylation of INPP5D exon CTD PMID:30157460 methimazole increases expression EXP 6480464 Methimazole results in increased expression of INPP5D mRNA CTD PMID:30047161 methylmercury chloride increases expression ISO INPP5D (Homo sapiens) 6480464 methylmercuric chloride results in increased expression of INPP5D mRNA CTD PMID:23179753 more ... methylmercury chloride multiple interactions ISO INPP5D (Homo sapiens) 6480464 [NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of INPP5D mRNA CTD PMID:27188386 N-ethyl-N-nitrosourea decreases expression ISO Inpp5d (Mus musculus) 6480464 Ethylnitrosourea results in decreased expression of INPP5D protein CTD PMID:32902906 N-nitrosodimethylamine increases expression EXP 6480464 Dimethylnitrosamine results in increased expression of INPP5D mRNA CTD PMID:25380136 nickel atom increases expression ISO INPP5D (Homo sapiens) 6480464 Nickel results in increased expression of INPP5D mRNA CTD PMID:24768652 and PMID:25583101 nickel dichloride affects expression EXP 6480464 nickel chloride affects the expression of INPP5D mRNA CTD PMID:22546817 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of INPP5D mRNA CTD PMID:25729387 ozone multiple interactions ISO INPP5D (Homo sapiens) 6480464 [Air Pollutants results in increased abundance of Ozone] which affects the expression of INPP5D mRNA and [Aripiprazole co-treated with Ozone] results in increased expression of INPP5D mRNA CTD PMID:31476115 and PMID:35430440 ozone multiple interactions ISO Inpp5d (Mus musculus) 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of INPP5D mRNA CTD PMID:34911549 ozone increases expression ISO INPP5D (Homo sapiens) 6480464 Ozone results in increased expression of INPP5D mRNA CTD PMID:31476115 p-chloromercuribenzoic acid increases expression ISO INPP5D (Homo sapiens) 6480464 p-Chloromercuribenzoic Acid results in increased expression of INPP5D mRNA CTD PMID:26272509 p-chloromercuribenzoic acid multiple interactions ISO INPP5D (Homo sapiens) 6480464 [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of INPP5D mRNA CTD PMID:27188386 panobinostat multiple interactions ISO INPP5D (Homo sapiens) 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of INPP5D mRNA CTD PMID:27188386 paracetamol affects expression ISO Inpp5d (Mus musculus) 6480464 Acetaminophen affects the expression of INPP5D mRNA CTD PMID:17562736 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of INPP5D mRNA CTD PMID:33387578 paracetamol increases expression ISO INPP5D (Homo sapiens) 6480464 Acetaminophen results in increased expression of INPP5D mRNA CTD PMID:22230336 paraquat multiple interactions ISO Inpp5d (Mus musculus) 6480464 [Maneb co-treated with Paraquat] results in decreased expression of INPP5D mRNA CTD PMID:36117858 perfluorooctanoic acid decreases expression EXP 6480464 perfluorooctanoic acid results in decreased expression of INPP5D mRNA CTD PMID:19162173 phenobarbital affects expression ISO INPP5D (Homo sapiens) 6480464 Phenobarbital affects the expression of INPP5D mRNA CTD PMID:19159669 phenylmercury acetate increases expression ISO INPP5D (Homo sapiens) 6480464 Phenylmercuric Acetate results in increased expression of INPP5D mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO INPP5D (Homo sapiens) 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of INPP5D mRNA CTD PMID:27188386 quercitrin affects expression ISO INPP5D (Homo sapiens) 6480464 quercitrin affects the expression of INPP5D mRNA CTD PMID:25193878 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO INPP5D (Homo sapiens) 6480464 [S-(1 more ... CTD PMID:35811015 SB 431542 multiple interactions ISO INPP5D (Homo sapiens) 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 silicon dioxide decreases expression ISO INPP5D (Homo sapiens) 6480464 Silicon Dioxide analog results in decreased expression of INPP5D mRNA CTD PMID:25895662 sodium arsenite increases expression ISO INPP5D (Homo sapiens) 6480464 sodium arsenite results in increased expression of INPP5D mRNA CTD PMID:29301061 and PMID:34032870 Soman increases expression EXP 6480464 Soman results in increased expression of INPP5D mRNA CTD PMID:19281266 sotorasib multiple interactions ISO INPP5D (Homo sapiens) 6480464 [sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of INPP5D mRNA CTD PMID:36139627 succimer multiple interactions ISO Inpp5d (Mus musculus) 6480464 [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of INPP5D mRNA CTD PMID:21641980 sunitinib increases expression ISO INPP5D (Homo sapiens) 6480464 Sunitinib results in increased expression of INPP5D mRNA CTD PMID:31533062 testosterone multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of INPP5D mRNA CTD PMID:32741896 tetrachloromethane multiple interactions ISO Inpp5d (Mus musculus) 6480464 [Carbon Tetrachloride co-treated with Ethanol] results in increased expression of INPP5D mRNA CTD PMID:30517762 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of INPP5D mRNA CTD PMID:34492290 titanium dioxide multiple interactions ISO Inpp5d (Mus musculus) 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of INPP5D mRNA CTD PMID:29950665 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of INPP5D mRNA CTD PMID:25729387 topotecan decreases expression EXP 6480464 Topotecan results in decreased expression of INPP5D mRNA CTD PMID:25729387 trametinib multiple interactions ISO INPP5D (Homo sapiens) 6480464 [sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of INPP5D mRNA CTD PMID:36139627 trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of INPP5D mRNA CTD PMID:33387578 trichostatin A increases expression ISO INPP5D (Homo sapiens) 6480464 trichostatin A results in increased expression of INPP5D mRNA CTD PMID:24935251 triptonide increases expression ISO Inpp5d (Mus musculus) 6480464 triptonide results in increased expression of INPP5D mRNA CTD PMID:33045310 tungsten decreases expression ISO Inpp5d (Mus musculus) 6480464 Tungsten results in decreased expression of INPP5D mRNA CTD PMID:30912803 urethane decreases expression ISO INPP5D (Homo sapiens) 6480464 Urethane results in decreased expression of INPP5D mRNA CTD PMID:28818685 valproic acid increases methylation ISO INPP5D (Homo sapiens) 6480464 Valproic Acid results in increased methylation of INPP5D gene CTD PMID:29154799 valproic acid decreases expression ISO INPP5D (Homo sapiens) 6480464 Valproic Acid results in decreased expression of INPP5D mRNA CTD PMID:28001369 valproic acid multiple interactions ISO INPP5D (Homo sapiens) 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of INPP5D mRNA CTD PMID:27188386 valproic acid increases expression ISO INPP5D (Homo sapiens) 6480464 Valproic Acid results in increased expression of INPP5D mRNA CTD PMID:23179753 more ... zinc protoporphyrin decreases expression EXP 6480464 zinc protoporphyrin results in decreased expression of INPP5D protein CTD PMID:25780291